Renovacareincis A Biotechnology Company Focused On Developing First Of Their Kind Autologousself Donatedstem Cell Therapies For Theregeneration Of Human Organsour Initial Products Under Development Target Thebody S Largest Organtheskinour Flagship Technologythecellmista C Systemuses Our Patented Skinguna C To Spray A Liquid Suspension Of A Patient S Stem Cells Ae Thecellmista C Solution Ae Onto Woundsin Investigativeclinical Usein Theunited Statesskinguna C Treatments Haveshown Thepotential To Naturally And Rapidly Heal Burns And Other Serious Woundswearedeveloping Our Cellmista C System As A Promising New Alternativefor Patients Suffering From Burnschronic And Acutewoundsand Scarsin Theus Alonethis $45 Billion Market Is Greater Than Spending On High Blood Pressuremanagementcholesterol Treatmentsand Back Pain Therapeutics
